CD8A and COVID-19: The increase in HLA-DR and CD38 expression associated with activation of CD8 and CD4 T cells in critical COVID-19 patients (37) has already been found in association with an increased frequency of terminally differentiated EMRA CD4+ and CD8+ cells.